[HTML][HTML] Cathepsin S (CTSS) activity in health and disease-A treasure trove of untapped clinical potential

P Smyth, J Sasiwachirangkul, R Williams… - Molecular aspects of …, 2022 - Elsevier
Amongst the lysosomal cysteine cathepsin family of proteases, cathepsin S (CTSS) holds
particular interest due to distinctive properties including a normal restricted expression …

Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications

S Xie, SC Xu, W Deng, Q Tang - Signal transduction and targeted …, 2023 - nature.com
Cardiac aging is evident by a reduction in function which subsequently contributes to heart
failure. The metabolic microenvironment has been identified as a hallmark of malignancy …

EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity

MK Gandhi, T Hoang, SC Law, S Brosda… - Blood, The Journal …, 2021 - ashpublications.org
Primary central nervous system lymphoma (PCNSL) is confined to the brain, eyes, and
cerebrospinal fluid without evidence of systemic spread. Rarely, PCNSL occurs in the …

Antibody–peptide conjugates deliver covalent inhibitors blocking oncogenic cathepsins

A Petruzzella, M Bruand… - Nature Chemical …, 2024 - nature.com
Cysteine cathepsins are a family of proteases that are relevant therapeutic targets for the
treatment of different cancers and other diseases. However, no clinically approved drugs for …

The fifth edition of the WHO classification of mature B‐cell neoplasms: open questions for research

SE Coupland, MQ Du, JA Ferry… - The Journal of …, 2024 - Wiley Online Library
The fifth edition of the World Health Organization Classification of Haematolymphoid
Tumours (WHO‐HAEM5) is the product of an evidence‐based evolution of the revised fourth …

COVID‐19 in patients receiving CD20‐depleting immunochemotherapy for B‐cell lymphoma

E Gaitzsch, V Passerini, E Khatamzas, CD Strobl… - …, 2021 - Wiley Online Library
The clinical and immunological impact of B‐cell depletion in the context of coronavirus
disease 2019 (COVID‐19) is unclear. We conducted a prospectively planned analysis of …

Pathogenesis of follicular lymphoma: genetics to the microenvironment to clinical translation

E Kumar, L Pickard, J Okosun - British Journal of Haematology, 2021 - Wiley Online Library
Follicular lymphoma (FL) represents a heterogeneous disease both clinically and
biologically. The pathognomonic t (14; 18) translocation can no longer be thought of as the …

Cysteine cathepsins as therapeutic targets in immune regulation and immune disorders

E Senjor, J Kos, MP Nanut - Biomedicines, 2023 - mdpi.com
Cysteine cathepsins, as the most abundant proteases found in the lysosomes, play a vital
role in several processes—such as protein degradation, changes in cell signaling, cell …

PARP14 is a novel target in STAT6 mutant follicular lymphoma

M Mentz, W Keay, CD Strobl, M Antoniolli, L Adolph… - Leukemia, 2022 - nature.com
The variable clinical course of follicular lymphoma (FL) is determined by the molecular
heterogeneity of tumor cells and complex interactions within the tumor microenvironment …

The clinical and molecular taxonomy of t (14; 18)-negative follicular lymphomas

I Salaverria, O Weigert… - Blood Advances, 2023 - ashpublications.org
Follicular lymphoma (FL) is a neoplasm derived from germinal center B cells, composed of
centrocytes and centroblasts, with at least a focal follicular growth pattern. The t (14; 18) …